Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Article Title: Time in Therapeutic Range for Left Ventricular Assist Device Patients Anticoagulated with Warfarin: A Correlation to Clinical Outcomes.

PMID/MRN: 27676409

Publication Date: 2016-Sep-22

Abstract:

Left ventricular assist devices (LVADs) require anticoagulation therapy with vitamin K antagonists to reduce the risk of thrombotic events. The quality of anticoagulation may be assessed by the time in therapeutic range (TTR). We analyzed a retrospective cohort of LVAD patients at a single institution from January 2012 to September 2014. Primary outcomes included TTR during the study time period and TTR 30 days preceding a bleeding or thrombotic event. Fifty-one patients (mean age 57.0 ± 14.6 years; 78% male) had an overall TTR of 52%. Median INR preceding a bleeding and thrombotic event was 2.7 and 2.2, respectively, (p=0.049). In the 30 days prior to an event, patients with a bleeding event were more likely to be on low dose aspirin (37% vs. 12%; p=0.018) and spend a higher proportion of time above therapeutic range (41% vs. 17%; p=0.007) compared to those with thrombotic events. The association between a greater percentage of time above therapeutic range in the 30 days prior to a bleeding event demonstrates the importance of avoiding a supratherapeutic INR in the LVAD patient population as well as the usefulness of TTR as a measure of the overall quality of anticoagulation and monitoring in an LVAD cohort.